In vivo studies in mouse models of lung adenocarcinoma showed that the genetic loss of YAP reduces the number of tumor masses experimentally induced in mice, while the knock-down of YAP or TAZ in human NSCLC cells impairs tumor formation after injection into nude mice [82,83]. This evidence concerns the gene YAP1 and lung adenocarcinoma.